Example: Heart Attack

Clinical Trials on Papilledema

Total 23 results

NCT02410148

Unknown status

aICP in Glaucoma and Papilledema

Conditions: Open-angle Glaucoma; Papilledema
NCT02992262

Unknown status

Ocular Point of Care Ultrasound (POCUS) to Detect Optic Disc Swelling in Comparison to Ophthalmologic Examination

Conditions: Papilledema Associated With Increased Intracranial Pressure
NCT02149615

Unknown status

Antiacne Medications Pseudotumor Cerebri

Conditions: Optic Disc Swelling
NCT03178760

Recruiting

Determination of Normal Measures of Optic Nerve Sheath Diameter in Children

Conditions: Optic Papilla Edema
NCT04448613

Active, not recruiting

Precise High Resolution MRI to Increase Accuracy and Gain Confidence to Diagnose Patients With Optic Disc Edema

Conditions: Optic Disk; Magnetic Resonance Imaging
NCT01170481

Completed

Assessment of Retinal Nerve Fibre Layer by Optical Coherence Tomography in Uveitis Patients With Papilloedema

Conditions: Uveitis; Glaucoma
NCT03273179

Unknown status

Cerebral Venous Sinus Thrombosis: Re-exploration of Clinical Assessment Scales

Conditions: Cerebral Venous Sinus Thrombosis; CSF Pressure Increased; Papilledema
NCT00069329

Terminated

Anakinra to Treat Patients With Neonatal Onset Multisystem Inflammatory Disease

Conditions: Nervous System Malformations; Arthropathy, Neurogenic; Urticaria; Papilledema
NCT02665858

Unknown status

OCT Imaging of Papilledema in Pediatric Idiopathic Intracranial Hypertension

Conditions: Pediatric Idiopathic Intracranial Hypertension
NCT03373292

Unknown status

Endovascular Stenting Treatment for Patients With Internal Jugular Vein Stenosis

Conditions: Stent Stenosis; Intracranial Hypertension; Headache; Tinnitus; Papilledema; Visual Impairment
NCT03590444

Completed

Treatment of Diabetic Macular Edema (DME) With Anti-VEGF and Focal Laser

Conditions: Diabetic Retinal Edema
NCT01847638

Completed

Prolensa (Bromfenac) 0.07% QD vs. Ilevro (Nepafenac) 0.3% QD for Treatment of Ocular Inflammation Post Cataract Surgery

Conditions: Cataract; Retinal Edema; Inflammation
NCT01487044

Available

A Single-Center Trial of High Frequency Pegaptanib for Rapid Restoration of VEGF Levels in Diabetic Retinal Edema

Conditions: Diabetic Macular Edema
NCT03753893

Active, not recruiting

Ocular Manifestations in Rheumatic Diseases

Conditions: Uveitis; Conjunctivitis; Keratoconjunctivitis Sicca; Xerophthalmia; Eye Hemorrhage; Optic Neuritis; Papilledema; Orbital Diseases; Retinal Vein Occlusion; Retinal Artery Occlusion; Macular Edema; Retinitis; Chorioretinitis; Iridocyclitis; Scleritis; Choroid Hemorrhage; Blindness; Amaurosis Fugax
NCT03071055

Active, not recruiting

Efficacy of Biweekly Ranibizumab (0.5 mg) for Exudative Macular Degeneration Retinal Edema Refractory to Anti-VEGF

Conditions: Exudative Age Related Macular Degeneration
NCT04501367

Not yet recruiting

Assessing the Efficacy and Safety fo DEXTENZA, Sustained Release Dexamethasone 0.4 mg Insert(s) for the Treatment of Pain, Inflammation, and Cystoid Macular Edema Following 27 Gauge Vitrectomy With Internal Limiting Membrane Peel for the Treatment of Retinal Edema Associated With Macular Pucker.

Conditions: Vitrectomy; Macular Pucker; Retinal Edema
NCT03490318

Unknown status

Effectiveness of Multimodal Imaging for the Evaluation of Retinal Oedema And New vesseLs in Diabetic Retinopathy

Conditions: Proliferative Diabetic Retinopathy; Diabetic Macular Edema
NCT01486238

Completed

Pegaptanib for Retinal Edema Secondary to Diabetic Vascular Disease(Preserve) Study

Conditions: Diabetic Macular Edema
NCT01318941

Completed

Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting

Conditions: Wet Age Related Macular Degeneration, Diabetic Macular Edema, Retinal Vein Occlusion; Wet Age Related Macular Degeneration; Diabetic Macular Edema; Retinal Vein Occlusion
NCT01273727

Completed

Ozurdex for Macular Edema Post Membrane Peeling

Conditions: Epiretinal Membrane; Cellophane Maculopathy; Macular Edema; Retinal Edema
NCT01003639

Completed

Idiopathic Intracranial Hypertension Treatment Trial

Conditions: Idiopathic Intracranial Hypertension
NCT02017444

Completed

Safety and Effectiveness of 11b-Hydroxysteroid Dehydrogenase Type 1 Inhibitor (AZD4017) to Treat Idiopathic Intracranial Hypertension.

Conditions: Idiopathic Intracranial Hypertension
NCT00769834

Withdrawn

Disc Edema in Patients With Chronic Kidney Disease

Conditions: Chronic Kidney Disease